Discovery offers an avenue for development of novel therapies for Chagas disease

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects some 8 million people worldwide. More than a third develop severe heart or digestive problems with a heightened risk of death.

Related Keywords

Brazil ,France ,Brazilian ,Edecio Cunha Neto ,Christophe Chevillard ,Emily Henderson ,Brazilian Society Of Cardiology ,Paulo Medical School ,Department Of Clinical Medicine ,Heart Institute ,World Health Organization ,Marseille University ,Medical School ,Clinical Medicine ,Aix Marseille University ,Genomics Industry Focus ,Brazilian Society ,Chagas Disease ,Enetic ,Flood ,Cardiomyopathy ,Fell ,Hronic ,Ytokine ,Cytoplasm ,Drugs ,Education ,Genes ,Enome ,Heart ,Interferon ,Interferon Gamma ,Metabolism ,Microscope ,Itochondria ,Utation ,Eurons ,Oxidative Stress ,Research ,Stress ,